Divaya Bhutani

13PUBLICATIONS
32CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 20, 2026
Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline Therapy.

|Mar 07, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.

George S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar

|Apr 15, 2025
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.

Noa Biran, Binod Dhakal, Ruben Niesvizky

|Feb 24, 2025
Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma Therapies.

Michael Sang Hughes, Metodi Balev, Jai Radhakrishnan

|Feb 05, 2025
Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody.

Divaya Bhutani, Rajshekhar Chakraborty, Karan Wats

|Sep 06, 2024
Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease.

Divaya Bhutani, Yusha Liu, Rajshekhar Chakraborty

Pageof 3

Frequent Collaborators

5 joint publications

Rajshekhar Chakraborty

2 joint publications

Michael Sang Hughes

2 joint publications

Anita D'Souza

2 joint publications

Binod Dhakal